Antineoplaston AS2-1 prolongs the recurrence-free interval between regional treatments and improves survival rate of these patients.

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.